|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10,450.00 GBX | -1.66% |
|
+1.10% | -0.17% |
| Jul. 11 | FDA May Fast Track Drug Reviews for Lower US Prices | MT |
| Jul. 11 | FDA May Fast Track Drug Reviews for Lower US Prices, Bloomberg Reports | MT |
Chart calendar AstraZeneca PLC
dcade1efd6612096801518.tQJS65RReLd2MNqbvYclAvmz-BL3qiNvvAyHezZGVzw.0mAr2q02Atw9X-7x1PBRM5DgnUODzm8exnnUD1UNAXrvLyWd0CkL0ydGkw~fceac42d00d9ae167a3f9148b66bf0d2
Upcoming events on AstraZeneca PLC
Past events on AstraZeneca PLC
Past dividends on AstraZeneca PLC
| 2025-02-19 | Final Payment 1.68 GBP |
| 2024-08-07 | Interim Payment 0.776 GBP |
| 2024-02-21 | Final Payment 1.56 GBP |
| 2023-08-09 | Interim Payment 0.718 GBP |
| 2023-02-22 | Final Payment 1.628 GBP |
| 2022-08-10 | Interim Payment 0.764 GBP |
| 2022-02-23 | Final Payment 1.453 GBP |
| 2021-08-11 | Interim Payment 0.648 GBP |
| 2021-02-24 | Final Payment 1.374 GBP |
| 2020-08-12 | Interim Payment 0.696 GBP |
| 2020-02-26 | Final Payment 1.464 GBP |
| 2019-08-07 | Interim Payment 0.719 GBP |
| 2019-02-27 | Final Payment 1.468 GBP |
| 2018-08-08 | Interim Payment 0.684 GBP |
| 2018-02-14 | Final Payment 1.336 GBP |
| 2017-08-09 | Interim Payment 0.689 GBP |
| 2017-02-15 | Final Payment 1.502 GBP |
| 2016-08-10 | Interim Payment 0.687 GBP |
| 2016-02-17 | Final Payment 1.31 GBP |
| 2015-08-12 | Interim Payment 0.575 GBP |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 44 351 44 465 -0.26% | 45 811 45 716 0.21% | 54 073 53 340 1.37% | 57 697 | 61 274 | 64 696 |
|
EBITDA Million USD | Released Forecast Spread | 9 237 13 681 -32.49% | 13 580 15 477 -12.26% | 16 691 16 909 -1.29% | 19 616 | 22 137 | 24 274 |
|
EBIT Million USD | Released Forecast Spread | 13 350 13 702 -2.57% | 14 534 15 036 -3.34% | 16 928 17 034 -0.63% | 18 511 | 20 872 | 23 019 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 2 501 3 511 -28.78% | 6 899 9 269 -25.57% | 8 691 10 318 -15.77% | 12 736 | 15 325 | 17 312 |
|
Net income Million USD | Released Forecast Spread | 3 288 4 262 -22.86% | 5 961 6 597 -9.64% | 7 035 8 172 -13.91% | 9 862 | 11 907 | 13 335 |
|
EPS USD | Released Forecast Spread | 2,11 2,81 -24.96% | 3,81 4,34 -12.22% | 4,50 5,33 -15.6% | 6,33 | 7,66 | 8,69 |
| Announcement Date | 09/02/23 | 08/02/24 | 06/02/25 | - |
Quarterly results
| Fiscal Period | March | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 11 492 11 529 -0.32% | 12 024 12 007 0.14% | 12 679 11 812 7.34% | 12 938 12 528 3.28% | 25 617 12 560 103.96% | 13 565 13 102 3.53% | 14 891 14 181 5.01% | 13 588 13 741 -1.11% | 14 061 | 14 558 | 15 320 | 14 260 | 14 597 | 15 134 | 15 859 |
|
EBITDA Million USD | Released Forecast Spread | 4 025 4 305 -6.51% | 3 923 4 265 -8.01% | 4 373 5 435 -19.54% | 4 958 5 324 -6.87% | 4 284 | 4 707 | 4 375 | ||||||||
|
EBIT Million USD | Released Forecast Spread | 3 545 3 537 0.24% | 2 752 3 206 -14.15% | 4 310 3 911 10.2% | 4 101 4 016 2.11% | 8 411 4 052 107.58% | 4 318 4 177 3.37% | 4 199 4 300 -2.34% | 4 803 4 583 4.81% | 4 437 | 4 521 | 4 390 | ||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 652 2 510 -34.17% | 897 1 671 -46.32% | 2 800 2 296 21.95% | 2 397 2 395 0.08% | 1 828 2 873 -36.37% | 1 666 2 825 -41.03% | |||||||||
|
Net income Million USD | Released Forecast Spread | 1 378 1 705 -19.16% | 959 2 313 -58.53% | 2 179 2 065 5.52% | 1 927 2 130 -9.52% | 1 429 2 332 -38.72% | 1 500 3 284 -54.32% | 2 916 2 458 18.63% | 2 466 | 2 647 | 2 236 | |||||
|
EPS USD | Released Forecast Spread | 0,89 1,09 -18.64% | 0,62 1,49 -58.3% | 1,41 1,33 6.28% | 1,24 1,36 -9% | 0,91 1,49 -39.13% | 0,96 2,11 -54.44% | 1,88 1,57 19.47% | 1,58 | 1,70 | 1,44 | |||||
| Announcement Date | 09/11/23 | 08/02/24 | 25/04/24 | 25/07/24 | 25/07/24 | 12/11/24 | 06/02/25 | 29/04/25 | - | - | - | - | - | - | - |
| 2025-07-15 | GLAND PHARMA LIMITED: Q1 2026 Earnings Release (Projected) |
| 2025-07-16 06:45 am | JOHNSON & JOHNSON: Q2 2025 Earnings Release |
| 2025-07-16 | NOVARTIS AG: Q2 2025 Earnings Release |
| 2025-07-17 01:00 am | CAMURUS AB: Q2 2025 Earnings Release |
| 2025-07-17 | JUBILANT PHARMOVA LIMITED: Q1 2026 Earnings Release (Projected) |
| 2025-07-18 05:00 am | ORION OYJ: Q2 2025 Earnings Release |
| 2025-07-22 | DR. REDDY'S LABORATORIES LIMITED: Q1 2026 Earnings Release |
| 2025-07-22 | LABORATORIOS FARMACEUTICOS ROVI, S.A.: Q2 2025 Earnings Release (Projected) |
| 2025-07-22 | GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.: Q2 2025 Earnings Release |
| 2025-07-23 01:00 am | COSMO PHARMACEUTICALS N.V.: Q2 2025 Earnings Release |
Past sector events for AstraZeneca PLC
| 2025-07-10 04:22 am | LOTUS PHARMACEUTICAL CO., LTD.: June 2025 Sales and Revenue Release |
| 2025-07-09 07:51 pm | BORA PHARMACEUTICALS CO., LTD.: June 2025 Sales and Revenue Release |
| 2025-07-09 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
| 2025-07-09 04:26 am | YUNGSHIN GLOBAL HOLDING CORPORATION: June 2025 Sales and Revenue Release |
| 2025-07-09 04:06 am | CALIWAY BIOPHARMACEUTICALS CO., LTD.: June 2025 Sales and Revenue Release |
| 2025-07-09 01:58 am | SYNMOSA BIOPHARMA CORPORATION: June 2025 Sales and Revenue Release |
| 2025-07-02 04:08 am | ONENESS BIOTECH CO., LTD.: June 2025 Sales and Revenue Release |
| 2025-06-17 11:45 am | MEDINCELL S.A.: Q4 2025 Earnings Release |
| 2025-06-10 04:38 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2025 Sales and Revenue Release |
| 2025-06-10 01:42 am | CENTER LABORATORIES, INC.: May 2025 Sales and Revenue Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AZN Stock
- Calendar AstraZeneca PLC
Select your edition
All financial news and data tailored to specific country editions
